VCA
NVO

Verdence Capital Advisors’s Novo Nordisk NVO Stock Holding History

Verdence Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,394
Closed -$274K – 725
2025
Q4 		$274K Sell
5,394
-28,409
-84% -$1.45M 0.02% 551
2025
Q3 		$1.79M Sell
33,803
-10,043
-23% -$588K 0.1% 195
2025
Q2 		$3.03M Buy
43,846
+63
+0.1% +$4.29K 0.21% 111
2025
Q1 		$3.04M Sell
43,783
-4,684
-10% -$387K 0.23% 106
2024
Q4 		$4.17M Buy
48,467
+5,490
+13% +$594K 0.34% 69
2024
Q3 		$5.12M Buy
42,977
+6,821
+19% +$910K 0.41% 57
2024
Q2 		$5.16M Sell
36,156
-44
-0.1% -$5.83K 0.46% 51
2024
Q1 		$4.65M Sell
36,200
-330
-0.9% -$39.3K 0.42% 57
2023
Q4 		$3.78M Buy
36,530
+3,360
+10% +$332K 0.37% 65
2023
Q3 		$3.02M Buy
33,170
+15,542
+88% +$1.37M 0.33% 78
2023
Q2 		$1.43M Buy
17,628
+9,516
+117% +$777K 0.17% 154
2023
Q1 		$645K Buy
8,112
+1,884
+30% +$134K 0.08% 263
2022
Q4 		$421K Buy
+6,228
New +$365K 0.05% 308

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Verdence Capital Advisors's NVO Position: Q1 2026 in Review

Verdence Capital Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,394 shares — an estimated $274K sold.

Verdence Capital Advisors first reported a position in NVO in Q4 2022 and held it in 13 quarters. The position peaked at $5.16M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Verdence Capital Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Verdence Capital Advisors sold 5,394 Novo Nordisk shares in Q1 2026, an estimated $274K.
  • Verdence Capital Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 13 quarters.
  • Verdence Capital Advisors's Novo Nordisk position peaked at $5.16M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.